New advice for NHS to ensure that vegovs and mounjaro such as Vagovi and Mounzaro should have a check-up, to ensure that they do not return the weight, there is new advice for NHS.
It is not uncommon for people to regain whatever they shed after stopping the treatment once, Experience show,
Guidance from Health Assessment Body Nice, warns weight management that there is a long -term journey, not short -term fix.
Patients may require additional support and a plan to live on their new weight, such as having healthy food and going to kill or walk to the gym.
In England alone, obesity affects one of the four adults.
One Estimated 1.5 million People are on weight loss jab in the UK, but the vast majority are paying privately for them, so they will not be eligible for NHS support as they come out of treatment.
Wegovy (semaglutide) is already available on NHS on prescription, but for only two years period for those (with their weight and health problems due to a high BMI).
About 240,000 people are expected to offer Mounjaro (Tirzepatide) over the next three years. There is currently no specified time limit to determine the drug.
Both medicines help reduce appetite and can cause life -changing weight loss. They are determined with programs that support healthy weight loss through diet and physical activity changes.
One in Vegi drug trialAfter coming out of the injection, the patients acquired two-thirds of their original weight. This is a similar story for those people Mounaro,
NICE, new advice from the National Institute for Health and Care Excellence, encourages patients to manufacture long-term behavior habits, uses self-spanning equipment, and “attracts wide support from online communities to family-led interventions and local activities.”
Prof. Jonathan Banger from Nice said: “Successful weight management does not end when the drug stops or when a behavior program completes.
“We know that the duration of infection after treatment is important, and people require structured support to maintain positive changes they have.”
Promila Hothorn, Promila Hothorn of the Royal College of GPS said: “No size of any size to deal with obesity is fit – the work that one patient works will probably not work for another.
“We need to focus more on prevention, prevent people from having overweight in the first place so that they do not need a medical intervention later.”
Obesity can cause people difficulties in their daily lives, and can put them at greater risk of serious health problems, such as heart disease, type 2 diabetes and certain types of cancer.
